Disclosed are compositions and methods for treating or preventing diseases or disorders associated with mitochondrial CaMKII activity.
Patent
Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity
United States Patent and Trademark Office
10/27/2015
Abstract
Details
- Title: Subtitle
- Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity
- Creators
- Mark E Anderson (Inventor)Mei-ling A Joiner (Inventor)Aliasger K Salem (Inventor)Amaraporn Wongrakpanich (Inventor)Frederick E Domann (Inventor)Duane D Hall (Inventor)Olha M Koval (Inventor)Douglas R Spitz (Inventor)
- Contributors
- University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
- Resource Type
- Patent
- Publisher
- United States Patent and Trademark Office; United States
- Patent
- US Patent 9,168,307; United States Patent and Trademark Office (United States, Alexandria) - PTO; Published; 14/017,847; 09/04/2013; 1/1
- Number of pages
- 23 pages
- Language
- English
- Date published
- 10/27/2015
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Pathology; Pharmaceutical Sciences and Experimental Therapeutics; Surgery; Radiation Oncology; Craniofacial Anomalies Research Center; Anesthesia; UI Research Foundation; Dental Research; Chemical and Biochemical Engineering; Internal Medicine
- Record Identifier
- 9983761991502771
Metrics
31 File views/ downloads
30 Record Views